While an impact on the immune system in gain-of-function mutations, such as the MECP2 duplication syndrome is evidenced [29, 30], no clinically relevant primary immune deficiency has been previously reported in either MECP2-RTT or CDKL5-RTT. Here, MECP2 is linked to Immunodeficiency.